Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Aug 18;140(7):669-670.
doi: 10.1182/blood.2022017209.

Isn't it ironic: better RBCs by blocking iron

Affiliations
Editorial

Isn't it ironic: better RBCs by blocking iron

Nermi L Parrow et al. Blood. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: R.E.F. is a member of the Scientific Advisory Board of Silence Therapeutics and receives research funding from Ultragenyx. R.E.F. and N.L.P. serve as consultants for Protagonist Therapeutics.

Comment on

References

    1. Nyffenegger N, Zennadi R, Kalleda N, et al. . The oral ferroportin inhibitor vamifeport improved hemodynamics in a mouse model of sickle cell disease. Blood. 2022;140(7): 769-781. - PMC - PubMed
    1. Das N, Xie L, Ramakrishnan SK, Campbell A, Rivella S, Shah YM. Intestine-specific disruption of hypoxia-inducible factor (HIF)-2α improves anemia in sickle cell disease. J Biol Chem. 2015;290(39):23523-23527. - PMC - PubMed
    1. Parrow NL, Violet PC, George NA, et al. . Dietary iron restriction improves markers of disease severity in murine sickle cell anemia. Blood. 2021;137(11):1553-1555. - PMC - PubMed
    1. Manolova V, Nyffenegger N, Flace A, et al. . Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia. J Clin Invest. 2019;130(1):491-506. - PMC - PubMed
    1. Drakesmith H, Nemeth E, Ganz T. Ironing out ferroportin. Cell Metab. 2015;22(5): 777-787. - PMC - PubMed